Apoptosis and clinical severity in patients with psoriasis and HCV infection
- PMID: 24891650
- PMCID: PMC4037940
- DOI: 10.4103/0019-5154.131377
Apoptosis and clinical severity in patients with psoriasis and HCV infection
Abstract
Background: It has been proposed that hepatitis C virus (HCV) antigens are involved in the pathogenesis of psoriasis and may contribute to severity of the disease. Increased expression of the apoptosis-regulating proteins p53 and tTG and decreased levels of bcl-2 in the keratinocytes of the skin of psoriatic patients have been reported.
Aim: This study aims to identify the serum levels of apoptosis-regulating proteins in patients with psoriasis and without HCV infection and to study the relation between clinical severity of psoriasis and the presence of HCV infection.
Materials and methods: Disease severity was assessed by psoriasis area severity index score (PASI) of 90 patients with psoriasis grouped as mild (n = 30), moderate (n = 30) and severe (n = 30); 20 healthy individuals were used as controls. All groups were subjected for complete history taking, clinical examination, and tests for liver function and HCV infection. The serum levels of apoptosis related proteins: p53, tTG and bcl-2 were estimated by enzyme linked immune sorbent assay (ELISA).
Results: There was a statistically significant (P < 0.001) correlation between clinical severity of psoriasis and presence of HCV antibodies and HCV-mRNA. In addition, significantly (P < 0.001) raised serum p53 and tTG, and reduced bcl-2 were observed among HCV-positive patients as compared to HCV-negative patients and control patients.
Conclusion: These results conclude that clinical severity of psoriasis is affected by the presence of HCV antibodies and overexpression of apoptotic related proteins. In addition, altered serum levels of apoptosis-regulating proteins could be useful prognostic markers and therapeutic targets of psoriatic disease.
Keywords: Apoptosis; B cell lymphoma-2 protein; Hepatitis C virus; P53; Psoriasis; tissue transglutaminase.
Conflict of interest statement
Similar articles
-
Study of the impact of viral load of hepatitis C on patients with concomitant psoriasis vulgaris.Arab J Gastroenterol. 2014 Sep-Dec;15(3-4):98-102. doi: 10.1016/j.ajg.2014.08.001. Epub 2014 Aug 28. Arab J Gastroenterol. 2014. PMID: 25174792
-
Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis.J Rheumatol. 1999 Feb;26(2):370-2. J Rheumatol. 1999. PMID: 9972971
-
[A study about hepatitis C virus infection in patients with psoriasis in a Brazilian reference center].Acta Gastroenterol Latinoam. 2012 Dec;42(4):285-90. Acta Gastroenterol Latinoam. 2012. PMID: 23383522 Spanish.
-
Management of psoriasis patients with hepatitis B or hepatitis C virus infection.World J Gastroenterol. 2016 Jul 28;22(28):6444-55. doi: 10.3748/wjg.v22.i28.6444. World J Gastroenterol. 2016. PMID: 27605880 Free PMC article. Review.
-
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1853-1859. doi: 10.1111/jdv.14146. Epub 2017 Feb 21. J Eur Acad Dermatol Venereol. 2017. PMID: 28146345 Review.
Cited by
-
Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.Acta Pharmacol Sin. 2016 Dec;37(12):1534-1542. doi: 10.1038/aps.2016.95. Epub 2016 Sep 26. Acta Pharmacol Sin. 2016. PMID: 27665848 Free PMC article.
-
Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis.Front Immunol. 2021 Oct 18;12:764384. doi: 10.3389/fimmu.2021.764384. eCollection 2021. Front Immunol. 2021. PMID: 34733291 Free PMC article. Review.
-
Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans.Int J Mol Sci. 2016 Sep 14;17(9):1551. doi: 10.3390/ijms17091551. Int J Mol Sci. 2016. PMID: 27649154 Free PMC article.
-
Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom.J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1674-1680. doi: 10.1111/jdv.14310. Epub 2017 Jun 1. J Eur Acad Dermatol Venereol. 2017. PMID: 28485831 Free PMC article.
References
-
- Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, et al. Immunopathogenesis of psoriasis. Exp Dermatol. 2007;16:779–98. - PubMed
-
- Cohen AD, Weitzman D, Birkenfeld S, Dreiher J. Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology. 2010;220:218–22. - PubMed
-
- Doutre MS. Hepatitis C virus-related skin diseases. Arch Dermatol. 1999;135:1401–3. - PubMed
-
- Chouela E, Abeldaño A, Panetta J, Ducard M, Neglia V, Sookoian S, et al. Hepatitis C virus antibody (anti-HCV): Prevalence in psoriasis. Int J Dermatol. 1996;35:797–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous